肿瘤患者癌性疼痛治疗依从性现状及其影响因素分析

doi:10.12183/j.scjpm.2022.0412

摘要/Abstract

摘要： 目的调查肿瘤患者癌性疼痛治疗依从性现状并分析其影响因素。方法选取2019年1—10月在成都某医院行癌性疼痛治疗的患者进行依从性现状调查,采用单、多因素方法分析其影响因素。结果 195名患者中,男122例,女73例,平均（63.10±11.72）岁。癌性疼痛治疗依从性得分为（0.91±1.40）,依从性好的患者有120例（61.5％）。二分类Logistic回归分析结果显示结算方式自费（OR=0.486）、肿瘤病程越长（OR=0.561）及无合并症（OR=2.395）是肿瘤患者癌痛治疗依从性的影响因素。结论肿瘤患者癌痛治疗依从性有待提高,医务人员应多关注患者依从性的影响因素,从而采取针对性措施提高患者治疗依从性。

关键词: 癌性疼痛, 依从性, 肿瘤患者

Abstract: Objective To investigate the compliance of cancer pain treatment in tumor patients and its influencing factors. Methods Patients who received cancer pain treatment in a Hospital of Chengdu from January to October 2019 were selected to investigate their compliance status, and the influencing factors were analyzed by univariate and multivariate analysis methods. Results Among the 195 patients, there were 122 males and 73 females, with an average age of （63.10±11.72） years. The score of compliance of cancer pain treatment was （0.91±1.40）, and there were 120 patients with good compliance （61.5%）. The results of binary logistic regression analysis showed that the settlement method at one's own expense （OR=0.486）, the longer the course of the tumor （OR=0.561）, and no complications （OR=2.395） were the influencing factors for the compliance of tumor patients with cancer pain treatment. Conclusion The compliance of cancer pain treatment in tumor patients needs to be improved. Medical staff should pay more attention to the influencing factors of compliance and take targeted measures to improve the compliance of patients.

Key words: Cancer pain, Compliance, Tumor patient

中图分类号:

R195

周瑶群, 方荣华. 肿瘤患者癌性疼痛治疗依从性现状及其影响因素分析[J]. 华南预防医学, 2022, 48(4): 412-415.

ZHOU Yao-qun, FANG Rong-hua. Compliance of cancer pain treatment in tumor patients and its influencing factors[J]. South China Journal of Preventive Medicine, 2022, 48(4): 412-415.

参考文献

[1] 吴玲玲,王吉平.护理干预对癌性疼痛病人疼痛管理影响的系统评价[J].护理研究,2016,30(7A):2322-2327.
[2] 周进,卢俊,石莉,等.癌性疼痛规范化治疗共识解读[J].中国医刊,2015,50(9):18-21.
[3] 周外平,华雷,李喜霞.单纯持续鞘内注射吗啡治疗老年晚期癌症重度癌性疼痛的效果[J].中国老年学杂志,2019,39(13):3145-3148.
[4] 汪业铭,李树铁,高艳.盐酸羟考酮缓释片与盐酸吗啡缓释片用于控制胰腺癌晚期癌痛的临床研究[J].中国临床药理学杂志,2019,35(19):2265-2267.
[5] 谭艳,李金花,李旭英,等.规范化癌痛管理模式下住院肿瘤患者疼痛现状调查[J].肿瘤药学,2020,10(5):627-630,640.
[6] 钟伟东,席加喜,张华君,等.2017—2018年某综合性三甲医院化疗病区NSCLC患者镇痛药物使用情况分析[J].肿瘤药学,2019,9(4):687-690.
[7] Torresan MM, Garrino L, Borraccino A, et al.Adherence to treatment in patient with severe cancer pain: A qualitative enquiry through illness narratives[J].Eur J Oncol Nurs,2015,19(4): 397-404.
[8] National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology(NCNN Guideline).Adult Cancer Pain,version 3.2019[EB/OL].(2019-06-24) [2021-06-05].https://www.nccn.org.
[9] 方荣华,邓学学,李蓉琼,等.实用全科护理手册[M].北京:科学出版社,2018:69-72.
[10] Morisky DE, Green LW, Levine DM.Concurrent and predictive validity of a self-reported measure of medication adherence[J].Med Care,1986,24(1),67-74.
[11] 潘秋香,谢艳萍,陈柳香.Morisky问卷调查癌痛病人口服药物依从性的信度和效度[J].全科护理,2019,17(19):2397-2398.
[12] 郭春平,杨晓雅,柯磊.原发性三叉神经痛患者抑郁发生情况及其影响因素分析[J].华南预防医学,2020,46(4):421-423.
[13] Mearis M, Shega JW, Knoebel RW.Does adherence to national comprehensive cancer network guidelines improve pain-related outcomes? An evaluation of inpatient cancer pain management at an academic medical center[J].J Pain Symptom Manage,2014,48(3): 451-458.
[14] Mantyh PW.Cancer pain and its impact on diagnosis, survival and quality of life[J].Nat Rev Neurosci,2006,7(10):797-809.
[15] 柳双燕,晋金兰.广州市重症监护室脓毒症心肌病患者睡眠状况调查[J].华南预防医学,2019,45(5):414-418.
[16] 欧阳雪岩,杨超,姜峰.癌性疼痛,肿瘤患者的严重威胁[J].生理学报,2019,71(2): 343-349.
[17] Kurita GP, De Mattos, Pimenta CA.Cognitive impairment in cancer pain patients receiving opioids: A pilot study[J].Cancer Nurs,2008,31(1):49-57.
[18] Banno B, Ickenstein LM, Chiu GN, et al.The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo[J].J Pharm Sci,2010,99(5):2295-2308.
[19] 夏姣燕. 老年肿瘤疼痛患者口服止痛药治疗依从性[J].中国老年学杂志,2015,35(10):2804-2805.
[20] 李小妹,施齐芳,李津.对癌症患者疼痛信念及遵医行为的研究[J].护理研究,2003,17(9A):996-999.
[21] 宋健,胡君娥,胡欢欢,等.住院癌痛患者服药依从性现状及影响因素分析[J].护理管理杂志,2017,17(7):463-465.
[22] 黎玲,远华,忠玉.慢性疼痛患者口服镇痛药的依从性调查[J].中国疼痛医学杂志,2014,20(9):679-680.
[23] Zenda S, Matsuura K, Tachibana H, et a1. Multicenter phase II study of an opioid-based pain control pmgram for head and neck cancer patients receiving chemoradiotherapy[J].Radiother Oncol,2011,101(3):410-414.
[24] Burkhart PV, Sabaté E.Adherence to long-term therapies: Evidence for action[J].J Nurs Scholarsh,2003,35(3):207.
[25] 王婷,王维利,丁金霞,等.消化系统癌症患者疼痛信念及感知的知性研究[J].中国实用护理杂志,2015,31(11):790-794.
[26] Sheinfeld Gorin S, Krebs P, Badr H, et al.Meta-analysis of psychosocial interventions to reduce pain in patients with cancer[J].J Clin Oncol,2012,30(5):539-547.
[27] 汪吕慧,刘建红,郑晓莉.肿瘤化疗患者不同病程焦虑抑郁状况的调查与分析[J].吉林医学,2012,33(1):135-137.
[28] 彭超华,曾铁英.护士视角下老年人自我忽视的内涵研究[J].护理学杂志,2018,33(20):90-92.
[29] 李莹,刘婷,姚新宇.居家男性痛风患者服药依从性及影响因素分析[J].护理学杂志,2019,34(17):79-82.
[30] Song Y, ScalesK, Anderson RA, et al. Resident challenges with daily life in Chinese long-term care facilities: A qualitative pilot study[J].Geriatr Nurs,2018,39(1):18-23.